TCI Wealth Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-63
Closed -$5K 2538
2021
Q1
$5K Buy
63
+35
+125% +$2.73K ﹤0.01% 1330
2020
Q4
$2K Hold
28
﹤0.01% 1310
2020
Q3
$1K Sell
28
-3
-10% -$148 ﹤0.01% 1504
2020
Q2
$1K Buy
31
+15
+94% +$560 ﹤0.01% 1423
2020
Q1
$1K Buy
16
+1
+7% +$57 ﹤0.01% 1416
2019
Q4
$1K Hold
15
﹤0.01% 1497
2019
Q3
$1K Hold
15
﹤0.01% 1454
2019
Q2
$1K Sell
15
-7
-32% -$492 ﹤0.01% 1374
2019
Q1
$1K Hold
22
﹤0.01% 1367
2018
Q4
$2K Hold
22
﹤0.01% 1098
2018
Q3
$2K Buy
+22
New +$2.1K ﹤0.01% 1117
2018
Q2
Sell
-22
Closed -$2K 1653
2018
Q1
$2K Hold
22
﹤0.01% 1042
2017
Q4
$2K Hold
22
﹤0.01% 1097
2017
Q3
$2K Hold
22
﹤0.01% 1024
2017
Q2
$2K Hold
22
﹤0.01% 1050
2017
Q1
$2K Hold
22
﹤0.01% 1002
2016
Q4
$2K Hold
22
﹤0.01% 1075
2016
Q3
$2K Hold
22
﹤0.01% 1030
2016
Q2
$2K Buy
22
+7
+47% +$483 ﹤0.01% 983
2016
Q1
$1K Buy
+15
New +$942 ﹤0.01% 1213

TCI Wealth Advisors's CMD Position: Q2 2021 in Review

TCI Wealth Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 63 shares — an estimated $5K sold.

TCI Wealth Advisors first reported a position in CMD in Q1 2016 and held it in 20 quarters. The position peaked at $5K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • TCI Wealth Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • TCI Wealth Advisors sold 63 Cantel Medical Corporation shares in Q2 2021, an estimated $5K.
  • TCI Wealth Advisors first reported a position in Cantel Medical Corporation in Q1 2016 and held it in 20 quarters.
  • TCI Wealth Advisors's Cantel Medical Corporation position peaked at $5K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on TCI Wealth Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.